NP / PA
Bouley, Jeffrey
Bouley, Jeffrey was paid $110K by Medicaid between Jul 2020 and Dec 2024, across 7 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 82% of everything it billed.
33Billing provider infoBOULEY, JEFFREY
WAKEFIELD, RI 02879
WAKEFIELD, RI 02879
33aNPI1104440965assigned 06/07/2020
33bProvider typeFamily Nurse Practitioner
28Total paid$110K
24GClaims2,438
24DCodes billed7
24AFirst – last monthJul 2020 – Dec 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Rhode Island
Rank by total paid#54 of 266
Median peer was paid$31K
This provider vs. median3.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 214 | $9K | |
| 2021 | 495 | $21K | |
| 2022 | 703 | $31K | |
| 2023 | 597 | $28K | |
| 2024incomplete | 429 | $22K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 82% | 1,947 | 1,864 | $90K |
| 87428 | 10% | 201 | 198 | $11K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4.0% | 45 | 45 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.5% | 82 | 76 | $2K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.3% | 26 | 26 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 122 | 121 | $1K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 15 | 13 | $552.36 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.